Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Poch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|May 8, 2013
In the clinic. Pulmonary hypertensionJess Mandel, David Poch
Annals of Internal Medicine|April 12, 2021
Pulmonary HypertensionDavid Poch, Jess Mandel
Pulmonary Circulation|June 9, 2021
Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertensionEhtisham Mahmud, Mitul Patel, Lawrence Ang, et al.
Pulmonary Circulation|December 7, 2020
Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registriesNick H Kim, Micah Fisher, David Poch, et al.
Critical Care Medicine|May 18, 2010
Mini-bronchoalveolar lavage quantitative polymerase chain reaction for diagnosis of methicillin-resistant Staphylococcus aureus pneumoniaDavid E Ost, David Poch, Abi Fadel, et al.
Interventional Cardiology Clinics|November 22, 2017
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionEhtisham Mahmud, Omid Behnamfar, Lawrence Ang, et al.
Journal of the American College of Cardiology|May 26, 2018
Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable DiseaseEhtisham Mahmud, Michael M Madani, Nick H Kim, et al.
Respiratory Research|February 4, 2021
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III studyHans Klose, Kelly M Chin, Ralf Ewert, et al.
The American Journal of Cardiology|August 3, 2012
Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertensionVinicio A de Jesus Perez, Erica Rosenzweig, Lewis J Rubin, et al.
Journal of the American College of Cardiology|October 1, 2021
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionKelly M Chin, Olivier Sitbon, Martin Doelberg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|May 8, 2013
In the clinic. Pulmonary hypertensionJess Mandel, David Poch
Annals of Internal Medicine|April 12, 2021
Pulmonary HypertensionDavid Poch, Jess Mandel
Pulmonary Circulation|June 9, 2021
Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertensionEhtisham Mahmud, Mitul Patel, Lawrence Ang, et al.
Pulmonary Circulation|December 7, 2020
Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registriesNick H Kim, Micah Fisher, David Poch, et al.
Critical Care Medicine|May 18, 2010
Mini-bronchoalveolar lavage quantitative polymerase chain reaction for diagnosis of methicillin-resistant Staphylococcus aureus pneumoniaDavid E Ost, David Poch, Abi Fadel, et al.
Interventional Cardiology Clinics|November 22, 2017
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionEhtisham Mahmud, Omid Behnamfar, Lawrence Ang, et al.
Journal of the American College of Cardiology|May 26, 2018
Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable DiseaseEhtisham Mahmud, Michael M Madani, Nick H Kim, et al.
Respiratory Research|February 4, 2021
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III studyHans Klose, Kelly M Chin, Ralf Ewert, et al.
The American Journal of Cardiology|August 3, 2012
Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertensionVinicio A de Jesus Perez, Erica Rosenzweig, Lewis J Rubin, et al.
Journal of the American College of Cardiology|October 1, 2021
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionKelly M Chin, Olivier Sitbon, Martin Doelberg, et al.
Pageof 2